Pervasive chromosomal instability and karyotype order in tumour evolution
暂无分享,去创建一个
George D. Cresswell | Z. Szallasi | N. Luscombe | P. Campbell | S. Loi | P. Brastianos | L. Yates | P. Van Loo | R. Schwarz | S. Horswell | G. Wilson | R. Cho | P. Savas | D. Moore | F. André | R. Rosenthal | M. Jamal-Hanjani | F. Castro-Giner | K. Harbst | G. Jönsson | N. Birkbak | S. Bakhoum | K. Haase | M. Dietzen | V. Tjan-Heijnen | L. Dyrskjøt | E. Lim | B. Bastian | I. Nordentoft | P. Lamy | T. Watkins | J. Demeulemeester | S. Turajlic | E. Grönroos | Hang Xu | K. Litchfield | L. Au | L. Spain | S. Dentro | C. Vicier | N. Steeghs | S. Dewhurst | F. Caramia | G. Cresswell | Maise Al Bakir | T. Mourikis | D. Biswas | F. Jaulin | Wei-Ting Lu | C. Swanton | N. Mcgranahan | M. Escudero | A. Rowan | I. Tomlinson | Marina Petković | S. Elizalde | G. Wilson
[1] Angela E. Leek,et al. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution , 2020, Nature Genetics.
[2] Nicholas D. Camarda,et al. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma , 2020, Nature Genetics.
[3] Benjamin J. Raphael,et al. Characterizing the allele- and haplotype-specific copy number landscape of cancer genomes at single-cell resolution with CHISEL , 2019 .
[4] P. Scheet,et al. Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer , 2019, Nature Biotechnology.
[5] A. van Oudenaarden,et al. Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids , 2019, Nature Genetics.
[6] L. Terracciano,et al. Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular Carcinoma , 2019, Scientific Reports.
[7] Z. Szallasi,et al. Neoantigen-directed immune escape in lung cancer evolution , 2019, Nature.
[8] S. Sleijfer,et al. Pan-cancer whole-genome analyses of metastatic solid tumours , 2018, bioRxiv.
[9] Jack Cuzick,et al. Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death , 2018, eLife.
[10] Sergi Elizalde,et al. A Markov chain for numerical chromosomal instability in clonally expanding populations , 2018, PLoS Comput. Biol..
[11] B. Taylor,et al. Genome doubling shapes the evolution and prognosis of advanced cancers , 2018, Nature Genetics.
[12] P. A. Futreal,et al. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal , 2018, Cell.
[13] Zoltan Szallasi,et al. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal , 2018, Cell.
[14] Steven J. M. Jones,et al. Comprehensive Characterization of Cancer Driver Genes and Mutations , 2018, Cell.
[15] F. Foijer,et al. Non-random Mis-segregation of Human Chromosomes , 2018, bioRxiv.
[16] Samuel F. Bakhoum,et al. Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.
[17] Angela E. Leek,et al. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution , 2017, Cell.
[18] P. Lønning,et al. Genomic Evolution of Breast Cancer Metastasis and Relapse , 2017, Cancer cell.
[19] Nicolai J. Birkbak,et al. Tracking the Evolution of Non‐Small‐Cell Lung Cancer , 2017, The New England journal of medicine.
[20] Ashwini Naik,et al. Phylogenetic ctDNA analysis depicts early stage lung cancer evolution , 2017, Nature.
[21] Jessica M. Rusert,et al. Extrachromosomal oncogene amplification drives tumor evolution and genetic heterogeneity , 2017, Nature.
[22] Stephane E. Castel,et al. Rare variant phasing and haplotypic expression from RNA sequencing with phASER , 2016, Nature Communications.
[23] A. Sablina,et al. Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism. , 2016, Cancer cell.
[24] Marc J. Williams,et al. Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.
[25] Sergi Elizalde,et al. Dynamics of Tumor Heterogeneity Derived from Clonal Karyotypic Evolution. , 2015, Cell reports.
[26] Andrew Menzies,et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing , 2015, Nature Medicine.
[27] M. Nykter,et al. The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.
[28] C. Curtis,et al. A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.
[29] Evis Sala,et al. Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis , 2015, PLoS medicine.
[30] Panagiotis Moulos,et al. Systematic integration of RNA-Seq statistical algorithms for accurate detection of differential gene expression patterns , 2014, Nucleic acids research.
[31] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[32] J. Wolchok,et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.
[33] C. Sima,et al. Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter, and Tumor Budding Are Independent Prognostic Factors for Worse Outcomes , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[34] G. McVean,et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications , 2014, Nature Genetics.
[35] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.
[36] James D. Brenton,et al. Phylogenetic Quantification of Intra-tumour Heterogeneity , 2013, PLoS Comput. Biol..
[37] S. Elledge,et al. Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome , 2013, Cell.
[38] S. Gabriel,et al. Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.
[39] Z. Szallasi,et al. Parallel evolution of tumour subclones mimics diversity between tumours , 2013, The Journal of pathology.
[40] Eric Lim,et al. Prognostic Significance of Predominant Histologic Pattern and Nuclear Grade in Resected Adenocarcinoma of the Lung: Potential Parameters for a Grading System , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[41] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[42] Francesca Chiaromonte,et al. A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome? , 2012, Genome research.
[43] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[44] R. Jessberger. 'Exploring aneuploidy: the significance of chromosomal imbalance' review series , 2012 .
[45] Y. Moreau,et al. Single-cell copy number variation detection , 2011, Genome Biology.
[46] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[47] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[48] C. Perou,et al. Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.
[49] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[50] Joseph T. Glessner,et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.
[51] Z. Szallasi,et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.
[52] L. Chin,et al. Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene , 2006, Cell.
[53] David Pellman,et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells , 2005, Nature.
[54] C. Ball,et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.
[55] J. Hartigan,et al. The Dip Test of Unimodality , 1985 .